Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Device-detected AF burden may enable tailored anticoagulation; leaves open randomized confirmation of net benefit.
Zimetbaum et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: